Related references
Note: Only part of the references are listed.Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group
Marie Meurer et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
High-grade endometrial stromal sarcoma: a retrospective study of factors influencing prognosis
Yan-Yan Zhang et al.
CANCER MANAGEMENT AND RESEARCH (2019)
A randomized phase II study of letrozole vs. observation in patients with newly diagnosed uterine leiomyosarcoma (uLMS)
Brian M. Slomovitz et al.
GYNECOLOGIC ONCOLOGY REPORTS (2019)
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. G. Casali et al.
ANNALS OF ONCOLOGY (2018)
Systemic treatment in adult uterine sarcomas
I. M. E. Desar et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Options for Adjuvant Therapy for Uterine Leiomyosarcoma
Claire F. Friedman et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Female Sex Hormone Receptor Profiling in Uterine Adenosarcomas
Jenna Z. Marcus et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)
Uterine Neoplasms, Version 1.2018 Clinical Practice Guidelines in Oncology
Wui-Jin Koh et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Uterine leiomyosarcoma: A review of the literature and update on management options
Maureen E. Roberts et al.
GYNECOLOGIC ONCOLOGY (2018)
Uterine sarcomas
Nomonde Mbatani et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study
Martee L. Hensley et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach
Margherita Nannini et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2018)
Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: Trends and survival outcomes
Ramey D. Littell et al.
GYNECOLOGIC ONCOLOGY (2017)
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial
Martee L. Hensley et al.
GYNECOLOGIC ONCOLOGY (2017)
Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study
Brandon-Luke L. Seagle et al.
GYNECOLOGIC ONCOLOGY (2017)
Clinicopathological characteristics and treatment strategies for patients with low-grade endometrial stromal sarcoma
Ran Cui et al.
MEDICINE (2017)
Uterine sarcoma - current perspectives
Charlotte Benson et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2017)
Uterine Adenosarcoma
Andre Pinto et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
William D. Tap et al.
LANCET (2016)
Uterine Adenosarcoma: a Review
Michael J. Nathenson et al.
CURRENT ONCOLOGY REPORTS (2016)
Influence of different treatment modalities on survival of patients with low-grade endometrial stromal sarcoma: A retrospective cohort study
Juan Zhou et al.
INTERNATIONAL JOURNAL OF SURGERY (2015)
Phase 2 Trial of Aromatase Inhibition With Letrozole in Patients With Uterine Leiomyosarcomas Expressing Estrogen and/or Progesterone Receptors
Suzanne George et al.
CANCER (2014)
Uterine adenosarcoma: An analysis on management, outcomes, and risk factors for recurrence
Amy Carroll et al.
GYNECOLOGIC ONCOLOGY (2014)
Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: A retrospective study of 153 cases
Huimin Bai et al.
GYNECOLOGIC ONCOLOGY (2014)
Gynecologic Cancer InterGroup (GCIG) Consensus Review for High-Grade Undifferentiated Sarcomas of the Uterus
Patricia Pautier et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors
Eirini Thanopoulou et al.
CLINICAL SARCOMA RESEARCH (2014)
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group
P. Pautier et al.
ANNALS OF ONCOLOGY (2013)
Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma Results of a Phase 2 Trial (SARC 005)
Martee L. Hensley et al.
CANCER (2013)
Management of uterine adenosarcomas with and without sarcomatous overgrowth
Edward J. Tanner et al.
GYNECOLOGIC ONCOLOGY (2013)
Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy
Gabriel G. Malouf et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2013)
Diagnosis and treatment of sarcoma of the uterus. A review
Claes G. Trope et al.
ACTA ONCOLOGICA (2012)
Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcorna
Mario M. Leitao et al.
GYNECOLOGIC ONCOLOGY (2012)
Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: Results from NORDCAN and NOCCA databases
R. Koivisto-Korander et al.
MATURITAS (2012)
Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy
X. Cheng et al.
GYNECOLOGIC ONCOLOGY (2011)
Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors
Roisin O'Cearbhaill et al.
GYNECOLOGIC ONCOLOGY (2010)
Long-term outcome and natural history of uterine adenosarcomas
Rebecca Arend et al.
GYNECOLOGIC ONCOLOGY (2010)
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study
Martee L. Hensley et al.
GYNECOLOGIC ONCOLOGY (2009)
Does Radiotherapy or Lymphadenectomy improve Survival in Endometrial Stromal Sarcoma?
Brandon Barney et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Clinical management of uterine sarcomas
Frederic Amant et al.
LANCET ONCOLOGY (2009)
The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma
Jason D. Wright et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas - Emphasis on impact of lymphadenectomy and oophorectomy
Daniel S. Kapp et al.
CANCER (2008)
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II:: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)
N. S. Reed et al.
EUROPEAN JOURNAL OF CANCER (2008)
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
Martee L. Hensley et al.
GYNECOLOGIC ONCOLOGY (2008)
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine lelomyosarcoma: A Gynecologic Oncology Group phase II trial
Martee L. Hensley et al.
GYNECOLOGIC ONCOLOGY (2008)
Low-grade endometrial stromal sarcoma: a single center's experience with 22 cases
W. Y. Kim et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
A multi-institutional review of outcomes of endometrial stromal sarcoma
Charles A. Leath et al.
GYNECOLOGIC ONCOLOGY (2007)
Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma
TI Wu et al.
GYNECOLOGIC ONCOLOGY (2006)
Gonadotropin-releasing hormone receptor expression in endometrial stromal sarcomas: an immunohistochemical study
O Reich et al.
MODERN PATHOLOGY (2005)
Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989-1999
BE Brooks et al.
GYNECOLOGIC ONCOLOGY (2004)
Aromatase cytochrome P450 and estrogen and progesterone receptors in uterine sarcomas: correlation with clinical parameters
Y Kitaoka et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma
F Amant et al.
GYNECOLOGIC ONCOLOGY (2004)
Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy
RL Giuntoli et al.
GYNECOLOGIC ONCOLOGY (2003)
Uterine sarcoma: Twenty-seven years of experience
L Livi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: Results of a phase II trial
ML Hensley et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Use of medroxyprogesterone acetate in the treatment of Mullerian adenosarcoma: A case report
BJ Hines et al.
GYNECOLOGIC ONCOLOGY (2002)
Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: Comparison of treatment and survival
TC Krivak et al.
GYNECOLOGIC ONCOLOGY (2001)
Radiation therapy in the treatment of endometrial stromal sarcoma
HD Weitmann et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma
DM Kushner et al.
GYNECOLOGIC ONCOLOGY (2000)
Share Paper
